⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 19, 2024European Journal of Nuclear Medicine and Molecular ImagingOpen Access

Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma

Wiebke Schloetelburg Philipp E. Hartrampf Aleksander Kosmala Sebastian E. Serfling Niklas Dreher Andreas Schirbel Martin Faßnacht Andreas K. Buck Rudolf A. Werner Stefanie Hahner

View Full Paper

Ask AI

Bookmark

Share

Abstract

In patients affected with adrenocortical carcinoma (ACC), C-X-C motif chemokine receptor 4 (CXCR4) is highly expressed in sites of disease in an ex-vivo setting. We aimed to determine the predictive value of CXCR4-targeting [

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schloetelburg et al. (2024) studied this question.

synapsesocial.com/papers/68e64185b6db6435875d30e3 https://doi.org/10.1007/s00259-024-06800-z

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Exploring Theranostic Avenues in Adrenocortical Carcinoma Using Chemokine Receptor and Prostate-Specific Membrane Antigen–Directed PET/CT2024 · 4 citations
2Prognostic value of chemokine receptor 4 expression in multiple myeloma patients2025
3Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR42024 · 5 citations
4CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerRetrospective Study · 2026 · 1 citations
5C-X-C Motif Chemokine Receptor 4–Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study2024